Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by bleedformeon Nov 23, 2009 10:54am
493 Views
Post# 16513965

RE: Seems to me that...Dr. Zamboni's

RE: Seems to me that...Dr. Zamboni's
Boy have you got it backwards. SSS's therapy repairs the damage to the brain by stimulating the new growth of neurons it does not stop the destruction of the myelin sheath. Your major veins will not constrict that much (85% as a example) even if you are completely immobile for years.Those patients in the program did not look like their heads or necks were immobile even a little bit. Perhaps you are thinking of collapsed veins which are a completely different from congenital malformation. Again SSS's therapy repairs the damage which is wonderful, Dr. Zamboni's treatment may very well stop the affliction.
Bullboard Posts